Filing Details
- Accession Number:
- 0001140361-11-044095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-30 17:42:42
- Reporting Period:
- 2011-08-26
- Filing Date:
- 2011-08-30
- Accepted Time:
- 2011-08-30 17:42:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1365916 | Amyris Inc. | AMRS | Industrial Organic Chemicals (2860) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1501908 | Joel Cherry | C/O Amyris, Inc. 5885 Hollis St., Suite 100 Emeryville CA 94608 | President Of R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-08-26 | 4,000 | $4.31 | 14,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-08-26 | 4,000 | $18.35 | 10,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-08-29 | 500 | $4.31 | 10,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-08-29 | 500 | $19.89 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-08-26 | 4,000 | $0.00 | 4,000 | $4.31 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-08-29 | 500 | $0.00 | 500 | $4.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 168,500 | 2019-09-13 | No | 4 | M | Direct | |
| 168,000 | 2019-09-13 | No | 4 | M | Direct |
Footnotes
- ***RULE 10B5-1 TRADING PLAN TRANSACTION: EACH OF THE FOREGOING OPTION EXERCISES AND STOCK SALES WAS EFFECTED PURSUANT TO A RULE 10B5-1 TRADING PLAN ADOPTED BY THE REPORTING PERSON ON DECEMBER 15, 2010.***
- Represents the aggregate of sales effected on the same day at different prices pursuant to the plan in footnote (1).
- Represents the weighted average sales price per share. The shares sold at prices ranging from $17.85 to $18.77 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Immediately exercisable.
- The stock option vested as to 1/5th of the total number of shares subject to the option on November 3, 2009, and thereafter vested and shall vest as to 1/60th of the total number of shares subject to the option in equal monthly installments.
Billionaire Hedge Funds
